Showing results (571-580 of 901) with videos related to
Sort By:
Pageof 91
Annals of Surgery|November 17, 2012
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapyJames D Smith, Jeannine A Ruby, Karyn A Goodman, et al.Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Prognostic Significance of CD8 T-cell Spatial Biomarkers in ER+ and ER- Breast CancerAndrew E Walker, Xiaohua Gao, Qichen Wang, et al.Journal of Pathology Informatics|April 20, 2013
A high-performance spatial database based approach for pathology imaging algorithm evaluationFusheng Wang, Jun Kong, Jingjing Gao, et al.Clinical Colorectal Cancer|December 3, 2014
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancerAndrea Cercek, Jinru Shia, Marc Gollub, et al.Cancer|April 30, 2008
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiationHak-Mien Quah, Joanne F Chou, Mithat Gonen, et al.Plos Medicine|October 15, 2025
Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER- breast cancer: A retrospective cohort studyAndrew E Walker, Xiaohua Gao, Qichen Wang, et al.The American Journal of Clinical Nutrition|April 1, 1976
Amino acid levels across normal forearm muscle and splanchnic bed after a protein mealT T Aoki, M F Brennan, W A Müller, et al.Biological Reviews of the Cambridge Philosophical Society|July 2, 2021
Anticipated effects of abiotic environmental change on intraspecific social interactionsDavid N Fisher, R Julia Kilgour, Erin R Siracusa, et al.The Oncologist|April 27, 2005
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forumRomán Pérez-Soler, Jean Pierre Delord, Allan Halpern, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumorsL B Saltz, J Kanowitz, N E Kemeny, et al.Pageof 91